BillionaireNet
family
A
Rank #1100
SWITZERLANDHealthcareMedical devices

Alberto Siccardi & family

Net Worth
$3.676B
+0.48% (24h)
Alberto Siccardi, a Swiss billionaire, is the founder of Medacta International, a prominent medical device company specializing in orthopedic products. Born in 1944, Siccardi's career began with a degree in pharmacy from the University of Turin and an MBA from SDA Bocconi School of Management. His career highlights include successfully expanding the family's medical device business, Bieffe Medital SPA, before selling it to Baxter Group in 1997. Dissatisfied with his hip replacement experience, he founded Medacta in 1999. Under his leadership as CEO and Chairman, Medacta has become a global player in the medical devices market, with a focus on innovative surgical solutions and patient care. Siccardi's net worth is estimated at $3.7 billion, and he currently holds the position of Chairman of the Board at Medacta.

The Full Dossier

Early Life and Education

Alberto Siccardi was born in 1944 and holds a degree in Pharmacy from the University of Turin (1969) and a Master's degree in Business Administration (MBA) from SDA Bocconi School of Management in Milan (1979).

Rise to Success

Siccardi's entrepreneurial journey began with his family's medical device company, Bieffe Medital SPA, which he successfully expanded internationally. In 1997, he sold the company to Baxter Group. In 1999, after experiencing dissatisfaction with his own hip replacement surgery, Siccardi founded Medacta International.

Key Business Strategies

Medacta's success is rooted in its focus on innovative orthopedic products and surgical techniques. The company's key strategies include:

  • Innovation: Pioneering innovative solutions for joint replacement and spinal surgery.
  • Patient-Centric Approach: Addressing patient needs through advanced technologies and minimally invasive surgical techniques.
  • Medical Education: Establishing educational platforms and training programs to support surgeons.

Medacta became a publicly listed company in April 2019, further solidifying its market position. The company's commitment to continuous improvement has driven its growth and impact in the medical device sector.

Philanthropy

While specific amounts are unavailable, Siccardi supports initiatives through Medacta for Life Foundation and other foundations, focusing on improving patient outcomes and medical education.

Career Timeline

2019

Medacta IPO

Medacta went public on the SIX Swiss Exchange.

2018

CEO Transition

Transitioned from CEO to Chairman of Medacta.

1999

Founded Medacta

Founded Medacta International.

1997

Sale of Bieffe Medital

Sold Bieffe Medital SPA to Baxter Group.

1979

MBA

Obtained a Master's degree in Business Administration (MBA) from SDA Bocconi School of Management in Milan.

1969

Graduation

Graduated with a degree in Pharmacy from the University of Turin.

Philanthropic Impact

Medical EducationUndisclosed

Medacta for Life Foundation

Supports various initiatives related to medical education and patient care.

Wealth Trajectory